3 results
Primary objectives: Dose-expansion:To evaluate the antitumor activity of MEDI0680 in combination with durvalumab versus nivolumab monotherapy in immunotherapy-naïve subjects with advanced or metastatic ccRCC as based on investigator assessed…
The main objective of the study is to test if burst SCS is clinically non-inferior to conventional SCS in patients already successfully treated with conventional SCS. The secondary objective of the study is to evaluate patient satisfaction and…
The objective of the study is to evaluate the benefit of the eCoach in the general practitioner*s office within cardiovascular risk management. Specifically, the eCoach evaluates the effect on individual risk factors and the risk on developing…